R. Barouki, X. Coumoul, and P. Fernandez-salguero, The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein, FEBS Letters, vol.21, issue.182, pp.3608-3615, 2007.
DOI : 10.1016/j.febslet.2007.03.046

A. Okey, D. Riddick, and P. Harper, The Ah receptor: Mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds???, Toxicology Letters, vol.70, issue.1, pp.1-22, 1994.
DOI : 10.1016/0378-4274(94)90139-2

M. Schwarz and K. Appel, Carcinogenic risks of dioxin: Mechanistic considerations, Regulatory Toxicology and Pharmacology, vol.43, issue.1, pp.19-34, 2005.
DOI : 10.1016/j.yrtph.2005.05.008

P. Fernandez-salguero, D. Hilbert, S. Rudikoff, J. Ward, and F. Gonzalez, Aryl-hydrocarbon Receptor-Deficient Mice Are Resistant to 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Toxicity, Toxicology and Applied Pharmacology, vol.140, issue.1, pp.173-179, 1996.
DOI : 10.1006/taap.1996.0210

B. Mcmillan and C. Bradfield, The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems, Molecular Pharmacology, vol.72, issue.3, pp.487-498, 2007.
DOI : 10.1124/mol.107.037259

H. Swanson, DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation, Chemico-Biological Interactions, vol.141, issue.1-2, pp.63-76, 2002.
DOI : 10.1016/S0009-2797(02)00066-2

N. Tijet, P. Boutros, I. Moffat, A. Okey, and J. Tuomisto, The aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries, Molecular Pharmacology, vol.69, pp.140-153, 2006.
DOI : 10.1124/mol.105.018705

B. Oesch-bartlomowicz and F. Oesch, Role of cAMP in mediating AHR signaling, Biochemical Pharmacology, vol.77, issue.4, pp.627-641, 2009.
DOI : 10.1016/j.bcp.2008.10.017

N. 'diaye, M. , L. Ferrec, E. Lagadic-gossmann, D. Corre et al., Aryl Hydrocarbon Receptor- and Calcium-dependent Induction of the Chemokine CCL1 by the Environmental Contaminant Benzo[a]pyrene, Journal of Biological Chemistry, vol.281, issue.29, pp.19906-19915, 2006.
DOI : 10.1074/jbc.M601192200
URL : https://hal.archives-ouvertes.fr/hal-00699622

F. Matsumura, The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects, Biochemical Pharmacology, vol.77, issue.4, pp.608-626, 2009.
DOI : 10.1016/j.bcp.2008.10.013

A. Puga, C. Ma, and J. Marlowe, The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways, Biochemical Pharmacology, vol.77, issue.4, pp.713-722, 2009.
DOI : 10.1016/j.bcp.2008.08.031

T. Hunter, Tyrosine phosphorylation: thirty years and counting, Current Opinion in Cell Biology, vol.21, issue.2, pp.140-146, 2009.
DOI : 10.1016/j.ceb.2009.01.028
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670436

D. Gilot, F. Giudicelli, D. Lagadic-gossmann, and O. Fardel, Akti-1/2; an allosteric inhibitor of Akt 1 and 2; efficiently inhibits CaMKIalpha activity and aryl hydrocarbon receptor pathway, Chem Biol Interact, 2010.

A. Braeuning and A. Buchmann, The Glycogen Synthase Kinase Inhibitor 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) Is a Partial Agonist of the Aryl Hydrocarbon Receptor, Drug Metabolism and Disposition, vol.37, issue.8, pp.1576-1580, 2009.
DOI : 10.1124/dmd.109.027821

P. Bachleda and Z. Dvorak, Pharmacological inhibitors of JNK and ERK kinases SP600125 and U0126 are not appropriate tools for studies of drug metabolism because they activate aryl hydrocarbon receptor, Gen Physiol Biophys, vol.27, pp.143-145, 2008.

P. Monteiro, D. Gilot, S. Langouet, and O. Fardel, Activation of the Aryl Hydrocarbon Receptor by the Calcium/Calmodulin-Dependent Protein Kinase Kinase Inhibitor 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid (STO-609), Drug Metabolism and Disposition, vol.36, issue.12, pp.2556-2563, 2008.
DOI : 10.1124/dmd.108.023333
URL : https://hal.archives-ouvertes.fr/hal-00673111

E. Han, H. Kim, J. Im, T. Jeong, and H. Jeong, Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium, Toxicology, vol.266, issue.1-3, pp.38-47, 2009.
DOI : 10.1016/j.tox.2009.10.013

C. Lin, S. Juan, C. Wang, Y. Sun, and C. Chou, Neuronal activity enhances aryl hydrocarbon receptor-mediated gene expression and dioxin neurotoxicity in cortical neurons, Journal of Neurochemistry, vol.18, issue.5, pp.1415-1429, 2008.
DOI : 10.1159/000087000

P. Monteiro, D. Gilot, L. Ferrec, E. Rauch, C. Lagadic-gossmann et al., Dioxin-Mediated Up-Regulation of Aryl Hydrocarbon Receptor Target Genes Is Dependent on the Calcium/Calmodulin/CaMKI?? Pathway, Molecular Pharmacology, vol.73, issue.3, pp.769-777, 2008.
DOI : 10.1124/mol.107.043125

O. Rodriguez-mora, M. Lahair, J. Mccubrey, and R. Franklin, Calcium/Calmodulin-Dependent Kinase I and Calcium/Calmodulin-Dependent Kinase Kinase Participate in the Control of Cell Cycle Progression in MCF-7 Human Breast Cancer Cells, Cancer Research, vol.65, issue.12, pp.5408-5416, 2005.
DOI : 10.1158/0008-5472.CAN-05-0271

E. Enan and F. Matsumura, Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway, Biochemical Pharmacology, vol.52, issue.10, pp.1599-1612, 1996.
DOI : 10.1016/S0006-2952(96)00566-7

M. Barhoover, J. Hall, W. Greenlee, and R. Thomas, Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4, Molecular Pharmacology, vol.77, issue.2, pp.195-201, 2010.
DOI : 10.1124/mol.109.059675

Z. Tan, M. Huang, A. Puga, and Y. Xia, A Critical Role For MAP Kinases in the Control of Ah Receptor Complex Activity, Toxicological Sciences, vol.82, issue.1, pp.80-87, 2004.
DOI : 10.1093/toxsci/kfh228

O. Pelz, M. Gilsdorf, and M. Boutros, web cellHTS2: A web-application for the analysis of high-throughput screening data, BMC Bioinformatics, vol.11, issue.1, p.185, 2010.
DOI : 10.1186/1471-2105-11-185

J. Mullenders and R. Bernards, Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer, Oncogene, vol.18, issue.50, pp.4409-4420, 2009.
DOI : 10.1016/j.cell.2008.09.061

G. Manning, D. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam, The Protein Kinase Complement of the Human Genome, Science, vol.298, issue.5600, pp.1912-1934, 2002.
DOI : 10.1126/science.1075762

R. Giet, C. Petretti, and C. Prigent, Aurora kinases, aneuploidy and cancer, a coincidence or a real link?, Trends in Cell Biology, vol.15, issue.5, pp.241-250, 2005.
DOI : 10.1016/j.tcb.2005.03.004
URL : https://hal.archives-ouvertes.fr/inserm-00966568

R. Piva, R. Chiarle, A. Manazza, R. Taulli, and W. Simmons, Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas, Blood, vol.107, issue.2, pp.689-697, 2006.
DOI : 10.1182/blood-2005-05-2125

S. Mahajan, S. Ghosh, E. Sudbeck, Y. Zheng, and S. Downs, Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton's Tyrosine Kinase (BTK), LFM-A13 [??-Cyano-??-Hydroxy-??-Methyl-N-(2,5-Dibromophenyl)Propenamide], Journal of Biological Chemistry, vol.274, issue.14, pp.9587-9599, 1999.
DOI : 10.1074/jbc.274.14.9587

C. Echeverri, P. Beachy, B. Baum, M. Boutros, and F. Buchholz, Minimizing the risk of reporting false positives in large-scale RNAi screens, Nature Methods, vol.3, issue.10, pp.777-779, 2006.
DOI : 10.1038/nmeth1006-777

M. Archuleta, G. Schieven, J. Ledbetter, G. Deanin, and S. Burchiel, 12-Dimethylbenz[a]anthracene activates protein-tyrosine kinases Fyn and Lck in the HPB-ALL human T-cell line and increases tyrosine phosphorylation of phospholipase C-gamma 1, formation of inositol 1,4,5-trisphosphate, and mobilization of intracellular calcium, Proc Natl Acad Sci, vol.7, issue.90, pp.6105-6109, 1993.

D. Davila, J. Lane, F. Lauer, and S. Burchiel, PROTEIN TYROSINE KINASE ACTIVATION BY POLYCYCLIC AROMATIC HYDROCARBONS IN HUMAN HPB-ALL T CELLS, Journal of Toxicology and Environmental Health, Part A, vol.56, issue.4, pp.249-261, 1999.
DOI : 10.1080/009841099158097

Y. Naito, Y. Watanabe, H. Yokokura, R. Sugita, and M. Nishio, Isoform-specific Activation and Structural Diversity of Calmodulin Kinase I, Journal of Biological Chemistry, vol.272, issue.51, pp.32704-32708, 1997.
DOI : 10.1074/jbc.272.51.32704

J. Condon, V. Pezzi, B. Drummond, S. Yin, and W. Rainey, Calmodulin-Dependent Kinase I Regulates Adrenal Cell Expression of Aldosterone Synthase, Endocrinology, vol.143, issue.9, pp.3651-3657, 2002.
DOI : 10.1210/en.2001-211359

S. Chen, T. Operana, J. Bonzo, N. Nguyen, and R. Tukey, ERK Kinase Inhibition Stabilizes the Aryl Hydrocarbon Receptor, Journal of Biological Chemistry, vol.280, issue.6, pp.4350-4359, 2005.
DOI : 10.1074/jbc.M411554200

Y. Wang, M. Liao, N. Hoe, P. Acharya, and C. Deng, A Role for Protein Phosphorylation in Cytochrome P450 3A4 Ubiquitin-dependent Proteasomal Degradation, Journal of Biological Chemistry, vol.284, issue.9, pp.5671-5684, 2009.
DOI : 10.1074/jbc.M806104200

B. Oesch-bartlomowicz and F. Oesch, Phosphorylation of cytochromes P450: First discovery of a posttranslational modification of a drug-metabolizing enzyme, Biochemical and Biophysical Research Communications, vol.338, issue.1, pp.446-449, 2005.
DOI : 10.1016/j.bbrc.2005.08.092

H. Gardner, J. Rajan, S. Ha, N. Copeland, and D. Gilbert, Cloning, Characterization, and Chromosomal Localization of Pnck, a Ca2+/Calmodulin-Dependent Protein Kinase, Genomics, vol.63, issue.2, pp.279-288, 2000.
DOI : 10.1006/geno.1999.6091

H. Xia and G. Yang, Inositol 1,4,5-trisphosphate 3-kinases: functions and regulations, Cell Research, vol.35, issue.2, pp.83-91, 2005.
DOI : 10.1016/S0005-2760(98)00132-5

O. Micheau, E. Solary, A. Hammann, F. Martin, and M. Dimanche-boitrel, Sensitization of Cancer Cells Treated With Cytotoxic Drugs to Fas-Mediated Cytotoxicity, JNCI Journal of the National Cancer Institute, vol.89, issue.11, pp.783-789, 1997.
DOI : 10.1093/jnci/89.11.783